Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Synergy Pharmaceuticals, Inc. (SGYP)

-NasdaqGS
4.34 0.06(1.36%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development16,449  10,782  9,055  14,344  
Selling General and Administrative2,908  2,692  2,803  3,278  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (19,357) (13,474) (11,858) (17,622)
Income from Continuing Operations
Total Other Income/Expenses Net(473)(63)1,819  (1,075)
Earnings Before Interest And Taxes(19,830)(13,537)(10,039)(18,697)
Interest Expense21   -   -   -  
Income Before Tax(19,851)(13,537)(10,039)(18,697)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(19,851)(13,537)(10,039)(18,697)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (19,851) (13,537) (10,039) (18,697)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (19,851) (13,537) (10,039) (18,697)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.